Express Scripts (Evernorth) denied your IVIG and immunoglobulin? Here is what to do next
Intravenous and subcutaneous immunoglobulin (IVIG, SCIG) is expensive, infused repeatedly, and reviewed against a short list of accepted diagnoses. This guide is specific to Express Scripts (Evernorth) appeals.
If Express Scripts (Evernorth) denied your IVIG and immunoglobulin, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: at least 180 days (employer self-funded plans); at least 180 days (insured and Marketplace plans). The date printed on your denial notice controls; it can only be later than these floors, never earlier.
Why Express Scripts (Evernorth) denies IVIG and immunoglobulin
Express Scripts is a pharmacy benefit manager owned by Cigna's Evernorth, and it decides drug coverage for employers, health plans and Medicare Part D sponsors rather than insuring you directly. That distinction is the reason most Express Scripts appeals go wrong: the denial arrives on Express Scripts letterhead, but the rules that govern your appeal come from whoever sponsors your plan. Sorting out which plan you are actually in is the first move, not an afterthought.
For IVIG and immunoglobulin specifically: Intravenous and subcutaneous immunoglobulin (IVIG, SCIG) is expensive, infused repeatedly, and reviewed against a short list of accepted diagnoses. Denials say 'not medically necessary' or 'experimental' for the specific condition, or move the drug to a different benefit or site of care.
Plans compare the diagnosis to their immunoglobulin policy, which typically lists FDA-labeled indications (primary immunodeficiency, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Kawasaki disease, and others) and selected off-label uses supported by published evidence. Medicare Part B covers immunoglobulin for primary immunodeficiency at home under 42 CFR 410.10 and the home IVIG benefit; other indications follow local coverage determinations in the Medicare Coverage Database. Plan criteria must be disclosed on request (29 CFR 2560.503-1(m)(8); 45 CFR 147.136).
Express Scripts (Evernorth) appeals: the rule, the deadline and the next level, by plan type
Which row applies depends on the plan you hold, not on Express Scripts (Evernorth)'s brand. Your ID card, the Summary Plan Description and the denial letter say which.
| Plan type | Rule that governs | File your appeal within | The plan must answer | If the plan says no again |
|---|---|---|---|---|
| Employer self-funded plan (ERISA) Most large employers. The employer pays the claims and hires the carrier to administer them; the Summary Plan Description says self-funded or self-insured. | ERISA § 503 (29 U.S.C. § 1133) and the claims-procedure rule, 29 CFR 2560.503-1. Federal external review under 45 CFR 147.136(d) for non-grandfathered plans. | At least 180 days from the adverse benefit determination (29 CFR 2560.503-1(h)(3)(i)). | Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days (29 CFR 2560.503-1(i)(2)). | Federal external review by an accredited independent review organization, requested within 4 months of the final internal denial (45 CFR 147.136(d)); then a civil action under ERISA § 502(a). State insurance departments do not regulate self-funded plans; the U.S. Department of Labor does. |
| Fully insured employer, individual or Marketplace plan The carrier holds the risk and is licensed in your state. Small employers and almost all individual and HealthCare.gov plans. | 45 CFR 147.136 (Public Health Service Act § 2719), which applies the 29 CFR 2560.503-1 procedures and adds state external review; state insurance law on top. | At least 180 days from the denial (45 CFR 147.136(b); 29 CFR 2560.503-1(h)(3)(i)). | Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days. Prior-authorization decisions by Marketplace issuers from 2026: 72 hours expedited, 7 calendar days standard (CMS-0057-F). | External review through your state's process, or the federal process where the state has none, generally within 4 months of the final internal denial (45 CFR 147.136(c), (d)). The state insurance department and its Consumer Assistance Program take complaints. |
What you can demand. The plan must give you the claim file, the internal rule or criterion it relied on, and the identity of the reviewer, free of charge, on request (29 CFR 2560.503-1(h)(2)(iii), (m)(8)).
How to open the appeal. Cite ERISA § 503 and 29 CFR 2560.503-1 in the opening paragraph: request the claim file and the specific criteria relied on, and note the 30-day (pre-service), 60-day (post-service) and 72-hour (urgent) decision clocks.
What you can demand. The plan must give you the claim file, the criteria it applied and any new evidence or rationale before the final decision, free of charge (45 CFR 147.136(b)(2)(ii)(C); 29 CFR 2560.503-1(h)(2)(iii)).
How to open the appeal. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right.
Primary sources for this table
- 29 CFR 2560.503-1, ERISA claims procedure
- 45 CFR 147.136, internal claims and appeals and external review
- U.S. Department of Labor, EBSA, health benefit claims and appeals
- HealthCare.gov, how to appeal an insurance company decision
- CMS-0057-F, prior-authorization decision timeframes from 2026
Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.
What Express Scripts (Evernorth) denies for IVIG and immunoglobulin
The IVIG and immunoglobulin services most often denied:
- IVIG for CIDP, myasthenia gravis, dermatomyositis, or autoimmune encephalitis
- Continuation after the initial authorization period when response is not documented
- Dose or frequency above the policy's stated range
- Site-of-care changes: hospital outpatient infusion moved to home or a standalone center
- Subcutaneous immunoglobulin when the plan prefers intravenous
Why IVIG and immunoglobulin claims get denied
A typical Express Scripts (Evernorth) IVIG and immunoglobulin denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Diagnosis not on the plan's list of covered indications
- Required baseline labs (immunoglobulin levels, vaccine response, nerve conduction studies) not in the record
- No documented failure of first-line therapy where the policy requires it
- Response to prior IVIG cycles not documented in measurable terms
- Plan classifies the use as experimental or investigational
The Express Scripts (Evernorth) appeal process
Appeal levels: An internal appeal to the plan, which Express Scripts administers, and then the external lane that matches your plan type: independent external review for commercial and employer plans, or the Part D appeals ladder through an independent review entity for Medicare.
Carrier timing: Employer and commercial plans generally allow at least 180 days from the denial to file the internal appeal. Medicare Part D runs on much shorter deadlines, and urgent requests are faster again. The date printed on your denial letter controls, and it is the date on the letter that starts the clock.
IVIG timing: Ongoing infusions make most IVIG appeals urgent: request expedited review and expect a decision within 72 hours (29 CFR 2560.503-1(f)(2)(i); 42 CFR 422.584 for Medicare Advantage). Internal appeal filing window: at least 180 days for commercial and employer plans; 65 days for Medicare Advantage; 60 days for Part D redetermination (42 CFR 423.582). External review must be requested within 4 months of the final internal denial for ACA-covered plans.
What we know about Express Scripts (Evernorth): Ask for two things in writing at the same time as the appeal: the specific coverage criteria the decision was applied against, and confirmation of whether your plan is self-funded or fully insured. The second answer determines your external-review route, and plans are required to tell you.
Common Express Scripts (Evernorth) denial patterns for IVIG and immunoglobulin
- Formulary exclusion mistaken for medical necessity. A large share of Express Scripts denials are formulary exclusions: the drug is not covered on your plan's list, regardless of whether it is right for you. Appealing that as a medical-necessity argument usually fails, because nobody disputed the medicine. The route is a formulary exception, which asks the plan to cover a non-covered drug because the covered alternatives are unsuitable, and it needs the prescriber to say why in clinical terms.
- Step therapy and the missing trial record. Express Scripts commonly requires documented trial and failure of preferred alternatives first. Denials cite the absence of that record far more often than they dispute the diagnosis. The fix is a prescriber statement naming each drug tried, the dose, the duration and the specific reason it was stopped. Most state step-therapy laws also allow an override where the alternative is contraindicated, was already tried, or is expected to be ineffective.
- The plan sponsor sets the appeal rules, not the PBM. If your plan is an employer self-funded plan, federal ERISA rules give you at least 180 days to appeal and entitle you to the criteria and the claim file on request. If it is a fully insured plan, your state's rules and external review apply. If it is Medicare Part D, a different and much faster set of deadlines applies. Express Scripts administers all three, so the letterhead tells you nothing about which clock you are on.
- Part D runs on a far shorter clock. Medicare Part D coverage determinations and redeterminations move in days, not months, and an expedited request compresses them further. Treating a Part D denial with a commercial-plan timetable is the most common way people lose the right to appeal it at all.
How to win your Express Scripts (Evernorth) IVIG and immunoglobulin appeal
Strategy for IVIG and immunoglobulin: Request the plan's immunoglobulin policy and the reviewer's specialty. Have the treating specialist write to each criterion: diagnosis with supporting labs or electrodiagnostic studies, prior therapies and results, measurable response to IVIG, and dosing rationale. For off-label uses, attach the guideline or peer-reviewed evidence the specialist relies on and identify it accurately. If the denial is 'experimental', the external review process specifically covers that determination (45 CFR 147.136(d)).
Filed against Express Scripts (Evernorth), that strategy rides on this procedural spine:
- Procedural-rights anchor. Cite ERISA § 503 and 29 CFR 2560.503-1 in the opening paragraph: request the claim file and the specific criteria relied on, and note the 30-day (pre-service), 60-day (post-service) and 72-hour (urgent) decision clocks. If your Express Scripts (Evernorth) coverage is a different plan type (Fully insured employer, individual or Marketplace plan), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
- Criteria-disclosure demand. Express Scripts (Evernorth) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. Plans compare the diagnosis to their immunoglobulin policy, which typically lists FDA-labeled indications (primary immunodeficiency, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, Kawasaki disease, and others) and selected off-label uses supported by published evidence. Medicare Part B covers immunoglobulin for primary immunodeficiency at home under 42 CFR 410.10 and the home IVIG benefit; other indications follow local coverage determinations in the Medicare Coverage Database. Plan criteria must be disclosed on request (29 CFR 2560.503-1(m)(8); 45 CFR 147.136).
- Treating-provider attestation. A letter from the treating physician addressing each criterion in Express Scripts (Evernorth)'s own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the IVIG and immunoglobulin denial and approve the service, not a general "please reconsider."
Documents you'll need for your Express Scripts (Evernorth) IVIG and immunoglobulin appeal
- The denial letter naming the criterion or policy applied
- Specialist's notes with diagnosis, labs, and electrodiagnostic or imaging results
- Record of prior therapies and outcomes
- Infusion records showing dose, frequency, and documented response
- The plan's immunoglobulin policy (request it in writing)
What a IVIG and immunoglobulin appeal can recover
Typical recovery for IVIG and immunoglobulin cases runs Immunoglobulin is among the most expensive recurring therapies; a denied course commonly represents thousands of dollars per infusion in billed charges.. The exact figure depends on the specific service and your plan's contracted rates.
Express Scripts (Evernorth) IVIG and immunoglobulin appeals: frequently asked questions
Express Scripts (Evernorth) says IVIG is experimental for my condition. Can that be appealed?
Yes. 'Experimental or investigational' determinations are appealable internally and are expressly within the scope of external review. The strongest appeals identify the published guideline or evidence the specialist relies on and show it directly.
My infusions are scheduled this week. What do I do first?
Ask for an expedited appeal in writing and have the prescriber confirm that delay could seriously jeopardize health. Expedited decisions are due within 72 hours.
Express Scripts (Evernorth) approved IVIG before. Why is it denied now?
Continuation reviews look for measurable response. If the record only says 'doing well', the plan may treat that as no evidence. The specialist's note should record the objective measures the policy asks for.
Does Express Scripts (Evernorth) have to tell me which policy it used?
For employer and ACA plans, yes: the internal rule, guideline, or protocol relied on must be provided free on request. Ask for it by name in the appeal.
What Apellica does for Express Scripts (Evernorth) IVIG and immunoglobulin appeals
We file appeals against Express Scripts (Evernorth) specifically configured to its internal review process. Every IVIG and immunoglobulin appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for Express Scripts (Evernorth) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your Express Scripts (Evernorth) IVIG and immunoglobulin appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Questions people ask next
- What does "not medically necessary" mean on a denial letter?
- My drug was denied as a formulary exclusion. How do I get an exception?
- External review of an insurance denial: how does it work?
What to read next
- Medical Necessity Denial: How to Appeal It — the full guide to this kind of denial, for any insurer
- IVIG and immunoglobulin appeal letter template — free, fill in your own details
- How IVIG and immunoglobulin denials are appealed
- Work out your own appeal deadline
Related Express Scripts (Evernorth) guides
- Express Scripts (Evernorth) medication and prescription denials appeal guide
- Express Scripts (Evernorth) prior authorization denials appeal guide
- Express Scripts (Evernorth) step therapy override denials appeal guide
- Express Scripts (Evernorth) biologic and infusion therapy denials appeal guide